Chargement en cours...
Targeting Protein Kinases to Enhance the Response to anti-PD-1/PD-L1 Immunotherapy
The interaction between programmed cell death protein (PD-1) and its ligand (PD-L1) is one of the main pathways used by some tumors to escape the immune response. In recent years, immunotherapies based on the use of antibodies against PD-1/PD-L1 have been postulated as a great promise for cancer tre...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6540309/ https://ncbi.nlm.nih.gov/pubmed/31075880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20092296 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|